The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,965,389 in first-year total cost, median $645,012.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-P (M2)]4
- Special Emphasis Panel[ZCA1 TCRB-D (M1)]4
- Special Emphasis Panel[ZCA1 RPRB-H (M2)]1
Most frequent institutions
- UNIVERSITY OF WISCONSIN-MADISON2
- DUKE UNIVERSITY1
- JOHNS HOPKINS UNIVERSITY1
- STANFORD UNIVERSITY1
- UNIV OF NORTH CAROLINA CHAPEL HILL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Targeting EBV-associated lymphomas1U01CA294800-01 | DAMANIA, BLOSSOM A | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $645,012 | ZCA1 |
| 2023 | Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)1U01CA275304-01A1 | DHARNIDHARKA, VIKAS R. | WASHINGTON UNIVERSITY, MO | $987,185 | ZCA1 |
| 2023 | Investigating the EBV methylome in PLWH: Discovery and Development of Novel EBV Diagnostics in Plasma and Saliva1U01CA284811-01 | AMBINDER, RICHARD FREDERICKXIAN, RENA | JOHNS HOPKINS UNIVERSITY, MD | $713,651 | ZCA1 |
| 2023 | Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease1U01CA275305-01A1 | KRAMS, SHERI M.MARTINEZ, OLIVIA M | STANFORD UNIVERSITY, CA | $627,903 | ZCA1 |
| 2023 | Roles of LMP1 and MYC in EBV-induced B-cell tumors1U01CA284614-01 | KENNEY, SHANNON CELESTE | UNIVERSITY OF WISCONSIN-MADISON, WI | $451,228 | ZCA1 |
| 2022 | B cell determinants of EBV latency1U01CA275301-01 | CESARMAN, ETHELGEWURZ, BENJAMIN ELISONROTH, LISA GIULINO | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $864,001 | ZCA1 |
| 2022 | Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV1U01CA275310-01 | BHADURI-MCINTOSH, SUMITAMCINTOSH, MICHAEL T | UNIVERSITY OF FLORIDA, FL | $689,270 | ZCA1 |
| 2022 | Defining and exploiting EBV-infected cell heterogeneity in non-Hodgkin lymphomas1U01CA275306-01 | LUFTIG, MICAH A. | DUKE UNIVERSITY, NC | $550,601 | ZCA1 |
| 2022 | Role of Epstein-Barr virus LMP2A protein in maintaining oncogenic IgM signaling in EBV+ B cell lymphomas1U01CA275247-01 | JOHANNSEN, ERIC C | UNIVERSITY OF WISCONSIN-MADISON, WI | $436,538 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.